Empagliflozin, a selective SGLT2 inhibitor, ameliorated hyperglycaemia and insulin resistance, while preserving the integrity of pancreas and kidney in CRDH ratsF. M. Younis,Z. Abassi,E. Mayoux,K. S. Hollander, L. Rath-Wolfson,T. RosenthalDIABETOLOGIA(2014)引用 0|浏览5暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要